SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Transl Med. 2019 12 26; 17(1):429.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
B7-H1 Antigen
Biomarkers, Tumor
Disease-Free Survival
Female
Humans
Male
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Risk Factors
Treatment Outcome

authors with profiles

Ezra Cohen